PL1615992T3 - Materiały wiążące białko prionowe i sposoby ich zastosowania - Google Patents

Materiały wiążące białko prionowe i sposoby ich zastosowania

Info

Publication number
PL1615992T3
PL1615992T3 PL04758843T PL04758843T PL1615992T3 PL 1615992 T3 PL1615992 T3 PL 1615992T3 PL 04758843 T PL04758843 T PL 04758843T PL 04758843 T PL04758843 T PL 04758843T PL 1615992 T3 PL1615992 T3 PL 1615992T3
Authority
PL
Poland
Prior art keywords
methods
protein binding
prion protein
binding materials
materials
Prior art date
Application number
PL04758843T
Other languages
English (en)
Inventor
Steven J Burton
David J Hammond
Ruben G Carbonell
Honglue Shen
Patrick V Gurgel
Viterose Wiltshire-Lyerly
Original Assignee
Pathogen Removal And Diagnostic Tech Inc
Univ North Carolina State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pathogen Removal And Diagnostic Tech Inc, Univ North Carolina State filed Critical Pathogen Removal And Diagnostic Tech Inc
Publication of PL1615992T3 publication Critical patent/PL1615992T3/pl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL04758843T 2003-04-04 2004-04-02 Materiały wiążące białko prionowe i sposoby ich zastosowania PL1615992T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US46047403P 2003-04-04 2003-04-04
PCT/US2004/010315 WO2004090102A2 (en) 2003-04-04 2004-04-02 Prion protein binding materials and methods of use
EP20040758843 EP1615992B1 (en) 2003-04-04 2004-04-02 Prion protein binding materials and methods of use

Publications (1)

Publication Number Publication Date
PL1615992T3 true PL1615992T3 (pl) 2014-03-31

Family

ID=33159772

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04758843T PL1615992T3 (pl) 2003-04-04 2004-04-02 Materiały wiążące białko prionowe i sposoby ich zastosowania

Country Status (15)

Country Link
US (1) US7393658B2 (pl)
EP (1) EP1615992B1 (pl)
JP (1) JP4783727B2 (pl)
CN (1) CN1842707B (pl)
AU (1) AU2004227389B2 (pl)
CA (1) CA2521438C (pl)
DK (1) DK1615992T3 (pl)
EG (1) EG26681A (pl)
ES (1) ES2436638T3 (pl)
IL (1) IL171279A (pl)
NZ (1) NZ543371A (pl)
PL (1) PL1615992T3 (pl)
PT (1) PT1615992E (pl)
SG (1) SG187269A1 (pl)
WO (1) WO2004090102A2 (pl)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2527408T3 (es) * 2002-12-03 2015-01-23 North Carolina State University Ligandos de proteínas priones y procedimientos de uso
JP4428616B2 (ja) * 2003-05-06 2010-03-10 オルガノ株式会社 グラフト修飾有機多孔質体及びその製造方法並びに吸着剤、クロマトグラフィー用充填剤及びイオン交換体
ES2398394T3 (es) 2003-08-13 2013-03-15 Novartis Vaccines And Diagnostics, Inc. Reactivos peptídicos específicos de prión
US20060035242A1 (en) * 2004-08-13 2006-02-16 Michelitsch Melissa D Prion-specific peptide reagents
US20050054003A1 (en) * 2003-09-10 2005-03-10 Stenland Christopher J. Prion clearance using particulate metal oxides
AP2006003861A0 (en) * 2004-06-09 2006-12-31 Pathogen Removal And Diagnosti Particles embedded in a porous substrate for removing target analyte from a sample
US20090130774A1 (en) * 2005-01-13 2009-05-21 David Peretz Elisa assays using prion-specific peptide reagents
WO2006076497A2 (en) * 2005-01-13 2006-07-20 Novartis Vaccines And Diagnostics Inc. Osplation of pathogenic prions
WO2006076683A2 (en) * 2005-01-13 2006-07-20 Novartis Vaccines And Diagnostics Inc. Isolation and detection of pathogenic prions
WO2007030804A1 (en) 2005-09-09 2007-03-15 Novartis Ag Prion-specific peptoid reagents
FR2891747B1 (fr) 2005-10-10 2007-12-14 Maco Pharma Sa Unite de filtration pour l'elimination selective d'une substance cible
WO2008001802A1 (en) * 2006-06-27 2008-01-03 Asahi Kasei Kabushiki Kaisha Substrate for biological fluid treatment
KR101170212B1 (ko) 2006-07-12 2012-07-31 아사히 가세이 메디컬 가부시키가이샤 혈액 제제로부터 이상 프리온을 제거하는 방법
JP2011520108A (ja) * 2008-04-30 2011-07-14 ノバルティス アーゲー 病原性配座異性体についてのアッセイ
HRP20192259T1 (hr) 2009-04-15 2020-03-06 Abraxis Bioscience, Llc Pripravci nanočestica bez priona i metode njihove proizvodnje
PL221899B1 (pl) * 2011-05-06 2016-06-30 Wrocławskie Centrum Badań Eit + Spółka Z Ograniczoną Czysta albumina oraz sposób jej otrzymywania i detekcji
FR2983735B1 (fr) * 2011-12-13 2019-12-13 Maco Pharma Nouvelle utilisation d'un materiau capable de lier la proteine prion
CA2995204A1 (en) 2015-08-10 2017-02-16 Essenlix Corp. Bio/chemical assay devices and methods for simplified steps, small samples, accelerated speed, and ease-of-use
US10132794B2 (en) 2015-09-14 2018-11-20 Essenlix Corporation Device and system for collecting and analyzing vapor condensate, particularly exhaled breath condensate, as well as method of using the same
KR20190057445A (ko) 2015-09-14 2019-05-28 에센릭스 코프. 샘플 특히 혈액샘플을 분석하기 위한 장치와 시스템 및 그 사용 방법
US10628693B2 (en) 2016-12-21 2020-04-21 Essenlix Corporation Devices and methods for authenticating a sample and use of the same
JP7003158B2 (ja) 2017-02-07 2022-01-20 エッセンリックス コーポレーション 圧縮開放流アッセイおよび使用
CA3052809A1 (en) 2017-02-08 2018-08-23 Essenlix Corporation Qmax assays and applications
CA3053002A1 (en) 2017-02-08 2018-08-16 Essenlix Corp. Bio/chemical material extraction and assay
CN122234927A (zh) 2017-02-08 2026-06-19 上海宜晟生物科技有限公司 通过控制温度的分子操作和检测
WO2018148470A1 (en) 2017-02-08 2018-08-16 Essenlix Corporation Sample collection and handling for delayed analysis
US12569851B2 (en) 2017-02-08 2026-03-10 Essenlix Corporation Digital assay
JP2020507770A (ja) 2017-02-09 2020-03-12 エッセンリックス コーポレーション 比色アッセイ法
CA3053114A1 (en) 2017-02-09 2018-08-16 Essenlix Corporation Assay using different spacing heights
CA3053132A1 (en) 2017-02-09 2018-08-16 Essenlix Corp. Assay with amplification
CA3053295A1 (en) 2017-02-15 2018-08-23 Essenlix Corporation Assay with rapid temperature change
CN111448449B (zh) 2017-02-16 2024-08-27 上海宜晟生物科技有限公司 采用纹理化表面的测定方法及装置
US12181472B2 (en) 2017-06-12 2024-12-31 Essenlix Corporation Homogeneous assay
US11725227B2 (en) 2017-08-01 2023-08-15 Essenlix Corporation Devices and methods for examining drug effects on microorganisms
US11280706B2 (en) 2017-08-01 2022-03-22 Essenlix Corporation Dilution calibration
CN111492222A (zh) 2017-08-01 2020-08-04 Essenlix公司 样品收集、保持和测定
WO2019075244A1 (en) 2017-10-11 2019-04-18 Essenlix Corporation CONTAINING A LIQUID SAMPLE
WO2019075415A1 (en) 2017-10-13 2019-04-18 Essenlix Corporation DEVICES AND METHODS FOR AUTHENTICATING MEDICAL ANALYSIS AND USES THEREOF
US11237113B2 (en) 2017-10-26 2022-02-01 Essenlix Corporation Rapid pH measurement
US10807095B2 (en) 2017-10-26 2020-10-20 Essenlix Corporation Making and tracking assay card
US11609224B2 (en) 2017-10-26 2023-03-21 Essenlix Corporation Devices and methods for white blood cell analyses
WO2019118652A1 (en) 2017-12-12 2019-06-20 Essenlix Corporation Sample manipulation and assay with rapid temperature change
CN112534259A (zh) 2017-12-14 2021-03-19 Essenlix公司 监测毛发的装置，系统和方法
WO2019140334A1 (en) 2018-01-11 2019-07-18 Essenlix Corporation Homogeneous assay (ii)
US11885952B2 (en) 2018-07-30 2024-01-30 Essenlix Corporation Optics, device, and system for assaying and imaging

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5133866A (en) 1988-03-24 1992-07-28 Terrapin Technologies, Inc. Method to identify analyte-bending ligands
US5010175A (en) 1988-05-02 1991-04-23 The Regents Of The University Of California General method for producing and selecting peptides with specific properties
AU6753390A (en) 1989-10-02 1991-04-28 University Of Michigan, The Bioanalytical detection system
US5498538A (en) 1990-02-15 1996-03-12 The University Of North Carolina At Chapel Hill Totally synthetic affinity reagents
US5650489A (en) 1990-07-02 1997-07-22 The Arizona Board Of Regents Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof
WO1993011155A1 (en) 1991-12-03 1993-06-10 Proteus Molecular Design Limited Fragments of prion proteins
US5312730A (en) 1992-05-27 1994-05-17 Ciba Corning Diagnostics Corp. Immune complex transfer with lypophilic bridge
JPH08178926A (ja) 1994-10-25 1996-07-12 Sumitomo Pharmaceut Co Ltd イムノアッセイプレートおよびその用途
US5834318A (en) 1995-05-10 1998-11-10 Bayer Corporation Screening of combinatorial peptide libraries for selection of peptide ligand useful in affinity purification of target proteins
US5750361A (en) 1995-11-02 1998-05-12 The Regents Of The University Of California Formation and use of prion protein (PRP) complexes
ATE249046T1 (de) * 1996-05-14 2003-09-15 Winnacker Ernst Ludwig Prof Chaperone, die prionproteine binden und zwischen den isoformen prpc und prpsc unterscheiden können
US5808011A (en) 1996-07-01 1998-09-15 Biopure Corporation Method for chromatographic removal of prions
US6221614B1 (en) * 1997-02-21 2001-04-24 The Regents Of The University Of California Removal of prions from blood, plasma and other liquids
US6750025B1 (en) * 1998-07-09 2004-06-15 V.I. Technologies, Inc. Method of detecting and isolating prion protein and variants thereof
US6437102B1 (en) * 1999-11-24 2002-08-20 Bayer Corporation Method of separating prions from biological materials
CA2405568A1 (en) * 2000-04-05 2001-10-18 North Carolina State University Prion-binding peptidic ligands and methods of using same
IES20010042A2 (en) * 2001-01-19 2002-12-11 Enfer Technology Ltd Test for transmissible spongiform encephalopathies
DE10107083C2 (de) * 2001-02-13 2003-02-20 Abdulgabar Salama Pentosan Polysulfat als Ligand zum Nachweis von Prionen
CA2407299A1 (en) 2001-08-13 2003-02-13 Douglas A. Campbell Peptide sequence tags and method of using same
DE10152677A1 (de) 2001-10-19 2003-05-08 Aventis Behring Gmbh Antikörper zum spezifischen Nachweis von pathogenen Prionen humanen Ursprungs und damit durchgeführten Nachweisverfahren

Also Published As

Publication number Publication date
WO2004090102A3 (en) 2006-03-16
PT1615992E (pt) 2013-11-29
CN1842707A (zh) 2006-10-04
US20050014196A1 (en) 2005-01-20
US7393658B2 (en) 2008-07-01
SG187269A1 (en) 2013-02-28
AU2004227389A1 (en) 2004-10-21
JP4783727B2 (ja) 2011-09-28
WO2004090102A2 (en) 2004-10-21
EP1615992B1 (en) 2013-08-28
CA2521438A1 (en) 2004-10-21
CA2521438C (en) 2014-03-25
HK1091894A1 (en) 2007-01-26
IL171279A (en) 2014-01-30
ES2436638T3 (es) 2014-01-03
JP2006522344A (ja) 2006-09-28
EP1615992A2 (en) 2006-01-18
CN1842707B (zh) 2012-06-27
EP1615992A4 (en) 2007-11-07
DK1615992T3 (da) 2013-12-09
AU2004227389B2 (en) 2010-09-16
NZ543371A (en) 2008-04-30
EG26681A (en) 2014-06-01

Similar Documents

Publication Publication Date Title
IL182422A0 (en) Prion protein binding materials and methods of use
EP1660013A4 (en) BIOMATERIAL AND PROTEIN BIOCOACERVATES, METHODS OF MAKING AND USING THEM
ZA200601653B (en) Binding constructs and methods for use thereof
IL169638A0 (en) Soluble fcyr fusion proteins and methods of use thereof
EP1482984A4 (en) REPLACEMENT ANTIBODIES AND METHOD FOR THEIR MANUFACTURE AND USE
IL178593A (en) Specific antibodies of fcγriib and methods for their use
LT2368907T (lt) Anti-abeta antikūnai ir jų panaudojimas
AU2003265522A1 (en) FCGammaRIIB-SPECIFIC ANTIBODIES AND METHODS OF USE THEREOF
PT1736541E (pt) Nova proteína galectina 9 modificada e sua utilização
EP1794589A4 (en) PROTEIN ARRAYS AND METHOD OF USE THEREOF
IL182749A0 (en) Vwfa and/or ant_ig domain containing proteins
GB0323238D0 (en) Synthetic LG binding domains of protein L
GB0326780D0 (en) Biological materials and uses thereof
EP1767634A4 (en) NEW GALECTIN 8 MODIFICATION PROTEIN AND USE THEREOF
GB0324457D0 (en) Modified peptides and their uses
EP1633850A4 (en) OVR115 ANTIBODY COMPOSITIONS AND METHODS OF USE
GB0416699D0 (en) Prion protein ligands and methods of use
GB0326778D0 (en) Biological materials and uses thereof
AU2003261362A8 (en) Lipid binding molecules and methods of use
AU2003296232A1 (en) A human liver regeneration associated protein and the use of it
EP1379548A4 (en) NEW BINDING INTERACTIONS OF THE RGS9 PROTEIN AND METHOD OF USE THEREOF
AU2003260487A8 (en) Novel pancortin-pablo protein interactions and methods of use thereof
EP1549951A4 (en) SEMAPHORIN-LIKE PROTEINS AND METHODS OF USE THEREOF
AU2003262895A8 (en) Carboxypeptidase b related polypeptides and methods of use
GB0224436D0 (en) Polypetides methods and means